95 related articles for article (PubMed ID: 21617210)
1. Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer.
Havelund BM; Sørensen FB; Lindebjerg J; Spindler KL; Jakobsen A
Anticancer Res; 2011 May; 31(5):1559-65. PubMed ID: 21617210
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer.
Havelund BM; Sørensen FB; Pløen J; Lindebjerg J; Spindler KL; Jakobsen A
APMIS; 2013 Feb; 121(2):127-38. PubMed ID: 23030583
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
Korkeila EA; Sundström J; Pyrhönen S; Syrjänen K
Anticancer Res; 2011 Dec; 31(12):4529-35. PubMed ID: 22199327
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
5. GLUT-1 expression and response to chemoradiotherapy in rectal cancer.
Brophy S; Sheehan KM; McNamara DA; Deasy J; Bouchier-Hayes DJ; Kay EW
Int J Cancer; 2009 Dec; 125(12):2778-82. PubMed ID: 19569052
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
7. Pronounced tumour regression after radiotherapy is associated with negative/weak glucose transporter-1 expression in rectal cancer.
Korkeila E; Jaakkola PM; Syrjänen K; Pyrhönen S; Sundström J
Anticancer Res; 2011 Jan; 31(1):311-5. PubMed ID: 21273616
[TBL] [Abstract][Full Text] [Related]
8. The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
Kao PS; Chang SC; Wang LW; Lee RC; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
J Surg Oncol; 2010 Dec; 102(7):771-7. PubMed ID: 20872811
[TBL] [Abstract][Full Text] [Related]
9. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
10. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
Zhou YL; Deng CS
Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
[TBL] [Abstract][Full Text] [Related]
11. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
12. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
13. Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer.
Korkeila E; Sundström J; Pyrhönen S; Syrjänen K
Anticancer Res; 2012 Aug; 32(8):3299-303. PubMed ID: 22843905
[TBL] [Abstract][Full Text] [Related]
14. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1alpha in rectal cancer.
Korkeila E; Jaakkola PM; Syrjänen K; Sundström J; Pyrhönen S
Scand J Gastroenterol; 2010 Mar; 45(3):340-8. PubMed ID: 20001759
[TBL] [Abstract][Full Text] [Related]
17. [Association of hypoxia-inducible factor 1α expression with microlymphatic vessel density and lymph node micrometastasis in rectal cancer].
Chang JC; Zhu GY; Yang JL; Zhang H; Wang DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Apr; 14(4):284-7. PubMed ID: 21538273
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor 1α predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer.
Shioya M; Takahashi T; Ishikawa H; Sakurai H; Ebara T; Suzuki Y; Saitoh J; Ohno T; Asao T; Kuwano H; Nakano T
J Radiat Res; 2011; 52(6):821-7. PubMed ID: 22104271
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
[TBL] [Abstract][Full Text] [Related]
20. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation.
Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A
Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
